Real-time Estimate
Cboe BZX
02:33:23 2024-06-07 pm EDT
|
5-day change
|
1st Jan Change
|
40.74
USD
|
-1.56%
|
|
-2.12%
|
+5.87%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
642.4
|
672.2
|
3,279
|
1,348
|
1,706
|
2,024
|
-
|
-
|
Enterprise Value (EV)
1 |
642.4
|
672.2
|
3,279
|
1,258
|
1,691
|
1,946
|
1,851
|
2,024
|
P/E ratio
|
47.2
x
|
18.1
x
|
45.1
x
|
27.4
x
|
29.7
x
|
27.7
x
|
23.4
x
|
18.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
0.3%
|
0.38%
|
-
|
Capitalization / Revenue
|
1.15
x
|
0.98
x
|
4.24
x
|
1.18
x
|
1.23
x
|
1.16
x
|
0.95
x
|
0.84
x
|
EV / Revenue
|
1.15
x
|
0.98
x
|
4.24
x
|
1.1
x
|
1.22
x
|
1.11
x
|
0.87
x
|
0.84
x
|
EV / EBITDA
|
8.62
x
|
5.31
x
|
18.9
x
|
8.99
x
|
11.5
x
|
11
x
|
8.97
x
|
8.45
x
|
EV / FCF
|
-
|
-
|
-
|
21.3
x
|
42.6
x
|
25.2
x
|
18.4
x
|
-
|
FCF Yield
|
-
|
-
|
-
|
4.7%
|
2.35%
|
3.97%
|
5.42%
|
-
|
Price to Book
|
-
|
-
|
-
|
2.49
x
|
2.92
x
|
2.88
x
|
2.63
x
|
-
|
Nbr of stocks (in thousands)
|
34,893
|
36,790
|
44,623
|
45,548
|
44,548
|
48,893
|
-
|
-
|
Reference price
2 |
18.41
|
18.27
|
73.48
|
29.59
|
38.30
|
41.39
|
41.39
|
41.39
|
Announcement Date
|
3/12/20
|
3/10/21
|
2/24/22
|
2/23/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
560.6
|
687.2
|
773.9
|
1,144
|
1,387
|
1,749
|
2,128
|
2,415
|
EBITDA
1 |
74.5
|
126.5
|
173.1
|
140
|
146.6
|
176.4
|
206.3
|
239.6
|
EBIT
1 |
34.41
|
80.5
|
98.18
|
104.3
|
84.61
|
128.7
|
144.8
|
183.5
|
Operating Margin
|
6.14%
|
11.71%
|
12.69%
|
9.11%
|
6.1%
|
7.36%
|
6.81%
|
7.6%
|
Earnings before Tax (EBT)
1 |
25.84
|
178.4
|
77.75
|
86.62
|
89.84
|
118.6
|
143.8
|
174.6
|
Net income
1 |
14.12
|
37.87
|
73.86
|
49.05
|
60.72
|
75.63
|
91.44
|
121.7
|
Net margin
|
2.52%
|
5.51%
|
9.54%
|
4.29%
|
4.38%
|
4.32%
|
4.3%
|
5.04%
|
EPS
2 |
0.3900
|
1.010
|
1.630
|
1.080
|
1.290
|
1.493
|
1.770
|
2.290
|
Free Cash Flow
1 |
-
|
-
|
-
|
59.19
|
39.7
|
77.29
|
100.4
|
-
|
FCF margin
|
-
|
-
|
-
|
5.17%
|
2.86%
|
4.42%
|
4.72%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
42.27%
|
27.08%
|
43.81%
|
48.66%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
120.67%
|
65.38%
|
102.19%
|
109.78%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
0.1249
|
0.1560
|
-
|
Announcement Date
|
3/12/20
|
3/10/21
|
2/24/22
|
2/23/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
195.1
|
-
|
-
|
317
|
294.2
|
337.2
|
348.2
|
348.2
|
353
|
404.4
|
436.7
|
447.5
|
459.2
|
486.3
|
504.5
|
EBITDA
1 |
38.74
|
-
|
-
|
57.14
|
23.65
|
29.82
|
35.77
|
51.97
|
29.01
|
42.24
|
45.98
|
49.2
|
39.17
|
51.47
|
52.47
|
EBIT
1 |
2.248
|
-
|
-
|
50.09
|
12.58
|
22.37
|
27.03
|
39.08
|
-3.87
|
30.14
|
32.94
|
34.82
|
26.93
|
42.5
|
40
|
Operating Margin
|
1.15%
|
-
|
-
|
15.8%
|
4.28%
|
6.63%
|
7.76%
|
11.23%
|
-1.1%
|
7.45%
|
7.54%
|
7.78%
|
5.86%
|
8.74%
|
7.93%
|
Earnings before Tax (EBT)
1 |
-22.43
|
-
|
-
|
41.26
|
10.46
|
19.41
|
31.49
|
38.02
|
0.924
|
24
|
34.92
|
37.27
|
24.76
|
36.9
|
34.4
|
Net income
1 |
13.77
|
-
|
-
|
25.99
|
-2.6
|
14.62
|
13.17
|
22.06
|
12.36
|
14.84
|
20.47
|
23.46
|
19.56
|
22.3
|
20.7
|
Net margin
|
7.06%
|
-
|
-
|
8.2%
|
-0.88%
|
4.34%
|
3.78%
|
6.34%
|
3.5%
|
3.67%
|
4.69%
|
5.24%
|
4.26%
|
4.59%
|
4.1%
|
EPS
2 |
0.3000
|
0.3100
|
0.2500
|
0.5600
|
-0.0600
|
0.3100
|
0.2800
|
0.4700
|
0.2600
|
0.3100
|
0.4114
|
0.4557
|
0.3114
|
0.4350
|
0.4300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/24/22
|
5/5/22
|
8/4/22
|
11/3/22
|
2/23/23
|
5/8/23
|
8/7/23
|
11/7/23
|
2/27/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
89.6
|
15.4
|
77.7
|
173
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
59.2
|
39.7
|
77.3
|
100
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
10.5%
|
19.2%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
11.90
|
13.10
|
14.40
|
15.70
|
-
|
Cash Flow per Share
2 |
-
|
-
|
-
|
1.800
|
1.450
|
0.8600
|
2.290
|
-
|
Capex
1 |
-
|
-
|
-
|
22.9
|
28.5
|
14.2
|
16.8
|
26.8
|
Capex / Sales
|
-
|
-
|
-
|
2%
|
2.06%
|
0.81%
|
0.79%
|
1.11%
|
Announcement Date
|
3/12/20
|
3/10/21
|
2/24/22
|
2/23/23
|
2/27/24
|
-
|
-
|
-
|
Last Close Price
41.39
USD Average target price
52.71
USD Spread / Average Target +27.36% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.07% | 2.02B | | +24.43% | 88.22B | | -22.82% | 76.5B | | +1.76% | 26.97B | | +7.59% | 18.61B | | -12.71% | 16.72B | | +3.45% | 15.85B | | +74.36% | 13.41B | | +78.22% | 13.16B | | +37.30% | 12.62B |
Other Healthcare Facilities & Services
|